NCT03282682

Brief Summary

This study examines the effect of 12-week strength training program with and without testosterone replacement therapy (TRT) on body composition, physical function, selected biochemical markers of metabolic health, molecular parameters of training adaptation and the quality of life patients with ADAM. The investigators believe, that strength training program performed 2 times per week for 12 weeks can improve body composition (decrease fat mass and gain lean mass), muscle strength, muscle power and general quality of life in all training groups. In addition, combination TRT and strength training could help decrease fat mass, improve BMI, cardio-respiratory fitness and thus provide optimal therapy combination for hypogonadal ageing males.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2017

Completed
25 days until next milestone

First Posted

Study publicly available on registry

September 14, 2017

Completed
17 days until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2019

Completed
11 months until next milestone

Results Posted

Study results publicly available

May 5, 2020

Completed
Last Updated

July 30, 2021

Status Verified

July 1, 2021

Enrollment Period

1.7 years

First QC Date

August 20, 2017

Results QC Date

February 23, 2020

Last Update Submit

July 15, 2021

Conditions

Keywords

hypogonadismaging malestrength trainingphysical activitytestosterone

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Lean Mass

    Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.

    7 days before intervention, 7 days after intervention

Secondary Outcomes (19)

  • Change From Baseline in Fat Mass

    7 days before intervention, 7 days after intervention

  • Change From Baseline in Total Body Mass

    7 days before intervention, 7 days after intervention

  • Change From Baseline in 10-m Usual Walk Test

    7 days before intervention, 7 days after intervention

  • Change From Baseline in 10-m Fast Walk Test

    7 days before intervention, 7 days after intervention

  • Change From Baseline in Handgrip Strength

    7 days before intervention, 7 days after intervention

  • +14 more secondary outcomes

Study Arms (3)

hypogonadal males without TRT

EXPERIMENTAL

Strength training

Procedure: Strength training

hypogonadal males with TRT

EXPERIMENTAL

Strength training and regular prescribed testosterone therapy given by participant urologist.

Procedure: Strength training

healthy eugonadal males

ACTIVE COMPARATOR

Strength training

Procedure: Strength training

Interventions

The participants perform strength training sessions two times per week for 12 weeks. Each training session include 5-minute general dynamic warm-up followed by progressive strength training with exercises for the entire body. The strength exercises are performed with free weights and on machines. The training program consist of 6 exercises for upper and lower body at an intensity of 60-80% (8 - 12RM: the load that induces technique failure in eight or twelve repetitions) of one-repetition maximum and takes approximately 60 minutes. The exercises performed are: leg press, split squats, bench press, knee extension, knee flexion, seated cable rows, seated cable pull downs, dumbbell bench press, incline dumbbell bench press.

healthy eugonadal maleshypogonadal males with TRThypogonadal males without TRT

Eligibility Criteria

Age45 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients of secondary hypogonadism on testosterone replacement therapy, newly diagnosed patients of secondary hypogonadism.

You may not qualify if:

  • Regular strength training, medical treating osteoporosis, abnormal digital rectal results, conditions which are medical contraindications (without adjusting state): diabetes mellitus, severe cardiac arrhythmia, uncontrolled hypertension, unstable angina pectoris, chronic obstructive pulmonary disease, epilepsy, unstable bone lesions with high risk of fracture, prostate cancer or abnormal serum PSA levels without adverse histological examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Comenius University in Bratislava, Faculty of physical education and sport

Bratislava, 814 69, Slovakia

Location

Related Publications (6)

  • Basaria S. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl. 2008 Sep-Oct;29(5):534-9. doi: 10.2164/jandrol.108.005454. Epub 2008 Jun 20.

  • Hildreth KL, Barry DW, Moreau KL, Vande Griend J, Meacham RB, Nakamura T, Wolfe P, Kohrt WM, Ruscin JM, Kittelson J, Cress ME, Ballard R, Schwartz RS. Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J Clin Endocrinol Metab. 2013 May;98(5):1891-900. doi: 10.1210/jc.2013-2227. Epub 2013 Mar 26.

  • Schwarz ER, Willix RD Jr. Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men. J Geriatr Cardiol. 2011 Dec;8(4):201-6. doi: 10.3724/SP.J.1263.2011.00201.

  • Kadi F, Bonnerud P, Eriksson A, Thornell LE. The expression of androgen receptors in human neck and limb muscles: effects of training and self-administration of androgenic-anabolic steroids. Histochem Cell Biol. 2000 Jan;113(1):25-9. doi: 10.1007/s004180050003.

  • Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014 Feb 1;32(4):335-46. doi: 10.1200/JCO.2013.49.5523. Epub 2013 Dec 16.

  • Kralik M, Cvecka J, Buzgo G, Putala M, Ukropcova B, Ukropec J, Killinger Z, Payer J, Kollarik B, Bujdak P, Raastad T, Sedliak M. Strength training as a supplemental therapy for androgen deficiency of the aging male (ADAM): study protocol for a three-arm clinical trial. BMJ Open. 2019 Sep 5;9(9):e025991. doi: 10.1136/bmjopen-2018-025991.

MeSH Terms

Conditions

EunuchismMotor ActivityHypogonadism

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Gonadal DisordersEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Limitations and Caveats

The major limit of the study was low number of the newly diagnosed patients.

Results Point of Contact

Title
Doc. Mgr. Milan Sedliak, PhD.
Organization
Comenius University in Bratislava

Study Officials

  • Milan Sedliak, assoc. prof.

    Comenius University of Bratislava, Faculty Physical Education and Sport

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: The study is 3 arms 12-week strength training program to assess the effect of testosterone replacement therapy (TRT) with strength training (ST) and strength training (ST) for hypogonadal patients without testosterone replacement therapy (NON-TRT) with control healthy eugonadal group, that is also engaged in strength training.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Independent researcher, Vice-dean for science, research and international cooperation

Study Record Dates

First Submitted

August 20, 2017

First Posted

September 14, 2017

Study Start

October 1, 2017

Primary Completion

May 30, 2019

Study Completion

May 30, 2019

Last Updated

July 30, 2021

Results First Posted

May 5, 2020

Record last verified: 2021-07

Locations